MILLIGAN JOHN F has filed 6 insider transactions across 3 companies since May 2024.
Most recent transaction: a grant/award of 38300 shares of Kailera Therapeutics, Inc. ($KLRA) on April 16, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 16, 2026 | Kailera Therapeutics, Inc. | $KLRA | MILLIGAN JOHN F | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2025 | 4D Molecular Therapeutics, Inc. | $FDMT | MILLIGAN JOHN F | Not found | A | Stock Option (Right to Buy) | 33750 | $0.00 | 33,750.0000 | 46,302,407 | 9999.99% | 0.07% |
| June 4, 2025 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | MILLIGAN JOHN F | Director | A | Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 297,852,228 | 9999.99% | 0.02% |
| June 18, 2024 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | MILLIGAN JOHN F | Director | A | Common Stock | 22821 | $0.00 | 132,821.0000 | 0 | 20.75% | 0.00% |
| June 18, 2024 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | MILLIGAN JOHN F | Director | A | Stock Option (right to buy) | 32179 | $0.00 | 32,179.0000 | 0 | 9999.99% | 0.00% |
| May 21, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | MILLIGAN JOHN F | Not found | A | Stock Option (Right To Buy) | 26791 | $0.00 | 26,791.0000 | 0 | 9999.99% | 0.00% |